A Cuproptosis-related lncRNA Signature for PrognosticStratification and Immunotherapeutic Implications in LungAdenocarcinoma
These findings suggest that CTLNS is a reliable biomarker for prognostic prediction and treatment stratification in LUAD, offering potential utility in personalized therapy.
Authors
- Xiang He (ORCID: https://orcid.org/0000-0002-2427-9048)
- Donghui Xing (ORCID: https://orcid.org/0000-0002-4357-2186)
- Wenqi Wu (ORCID: https://orcid.org/0000-0002-6184-8668)
- Jing Guo (ORCID: https://orcid.org/0000-0001-9050-4947)
- Kaiping Luo
- Jinhuan Wang (ORCID: https://orcid.org/0000-0002-7111-4318)
- C. Li
- Yixin Zhai
- Yanan Jiang
- Zhigang Zhao
Institutions
- Tianjin First Center Hospital (CN)
- Tianjin Medical University Cancer Institute and Hospital (CN)
- Tianjin Medical University (CN)
Publication Details
- Journal
- Current Molecular Medicine
- Published
- 2026-01-08
- DOI
- https://doi.org/10.2174/0115665240355806250718044011
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00